GlobeNewswire 04-16 Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization o...
GlobeNewswire 04-10 Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer R...
GlobeNewswire 04-09 Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a N...
GlobeNewswire 03-26 SERVPRO Welcomes Accomplished Leader as New Chief Technology Officer
GlobeNewswire 02-29 Brink's Announces Fourth-Quarter and Full-Year 2023 Results
GlobeNewswire 02-05 Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in...
GlobeNewswire 01-25 Atlas Air Worldwide Announces Appointment of Joel Goldberg as Executive Vice President and Chief Inf...
GlobeNewswire 2023-11-14 Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023
GlobeNewswire 2023-11-07 Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Tre...
GlobeNewswire 2023-11-07 Brink's Announces Record Third-Quarter Results
GlobeNewswire 2023-10-23 Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at AACR Special Conf...
GlobeNewswire 2023-09-27 Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Canc...
GlobeNewswire 2023-08-17 Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment...
GlobeNewswire 2023-08-15 Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 3...
GlobeNewswire 2022-03-22 Qualigen Therapeutics Announces Three Published Abstracts at American Association of Cancer Research...
GlobeNewswire 2022-03-15 Qualigen Therapeutics Extends Research Agreement with University of Louisville Research Foundation o...
GlobeNewswire 2022-02-23 Brink’s Reports Record Revenue and Operating Profit for Fourth-Quarter and Full-Year
GlobeNewswire 2022-02-22 Qualigen Therapeutics CEO Michael Poirier Provides Letter to Shareholders
GlobeNewswire 2022-02-15 Data from Qualigen Therapeutics’ Lead Program QN-302 Accepted as Three Poster Presentations at AACR ...
GlobeNewswire 2022-02-01 Qualigen Therapeutics Engages Professor Stephen Neidle as Scientific Advisor in the Development of L...
GlobeNewswire 2022-01-18 Qualigen Therapeutics Secures Worldwide Rights to G4-Selective Transcription Inhibitors from Univers...
GlobeNewswire 2021-10-27 Brink's Reports Third-Quarter Results
GlobeNewswire 2021-10-12 Webtel.mobi’s System Brings the World’s 2 Billion Unbanked Persons – And Global Cash Use – Into a Gl...
GlobeNewswire 2021-09-23 Brink’s Provides Business Update, Revises 2021 Guidance
GlobeNewswire 2021-09-01 Face Recognition Leader Paravision Names Security Industry Veteran Kurt Takahashi to Board of Direct...